Completed
Bortezomib and Gemcitabine in Treating Patients With Recurrent or Metastatic Nasopharyngeal Cancer
NCT00305734
- Conditions
- Head and Neck Neoplasms, Nasopharyngeal Diseases, Nasopharyngeal Neoplasms, +9 more
- Locations
-
- Southwest Oncology Group San Antonio, Texas, United States